Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/201162
Title: | Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice |
Author: | Soler Vázquez, M. Carmen Romero Romero, María del Mar Todorčević, Marijana Delgado, Katia Calatayud Aristoy, Carles Benítez Amaro, Aleyda La Chica Lhoëst, Maria Teresa Mera Nanín, Paula Zagmutt Caroxa, Sebastián Bastías-Pérez, Marianela Ibeas, Kevin Casals, Núria Escolà Gil, Joan Carles Llorente Cortés, Vicenta Consiglio, Antonella Serra i Cucurull, Dolors Herrero Rodríguez, Laura |
Keywords: | Obesitat Teixit adipós Inflamació Glucosa Ratolins (Animals de laboratori) Obesity Adipose tissues Inflammation Glucose Mice (Laboratory animals) |
Issue Date: | May-2023 |
Publisher: | Elsevier |
Abstract: | Obesity and its associated metabolic comorbidities are a rising global health and social issue, with novel therapeutic approaches urgently needed. Adipose tissue plays a key role in the regulation of energy balance and adipose tissue-derived mesenchymal stem cells (AT-MSCs) have gained great interest in cell therapy. Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation. Here, we aimed to generate adipocytes expressing a constitutively active CPT1A form (CPT1AM) that can improve the obese phenotype in mice after their implantation. AT-MSCs were differentiated into mature adipocytes, subjected to lentivirus-mediated expression of CPT1AM or the GFP control, and subcutaneously implanted into mice fed a high-fat diet (HFD). CPT1AM-implanted mice showed lower body weight, hepatic steatosis and serum insulin and cholesterol levels alongside improved glucose tolerance. HFD-induced increases in adipose tissue hypertrophy, fibrosis, inflammation, endoplasmic reticulum stress and apoptosis were reduced in CPT1AM-implanted mice. In addition, the expression of mitochondrial respiratory chain complexes was enhanced in the adipose tissue of CPT1AM-implanted mice. Our results demonstrate that implantation of CPT1AM-expressing AT-MSC-derived adipocytes into HFD-fed mice improves the obese metabolic phenotype, supporting the future clinical use of this ex vivo gene therapy approach. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.ymben.2023.04.010 |
It is part of: | Metabolic Engineering, 2023, vol. 77, p. 256-272 |
URI: | http://hdl.handle.net/2445/201162 |
Related resource: | https://doi.org/10.1016/j.ymben.2023.04.010 |
ISSN: | 1096-7176 |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Fisiologia) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) Articles publicats en revistes (Patologia i Terapèutica Experimental) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
733485.pdf | 11.56 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License